NEW YORK, December 6, 2016 /PRNewswire/ --
Stock-Callers.com revisits the Healthcare sector to evaluate the most recent performances of some equities. In today's lineup are: Skyline Medical Inc. (NASDAQ: SKLN), Baxter International Inc. (NYSE: BAX), DENTSPLY Sirona Inc. (NASDAQ: XRAY), and InspireMD Inc. (NYSEMKT: NSPR). According to a new study released on Friday, December 02, 2016, by the Office of the Actuary at the Centers for Medicare and Medicaid Services, US healthcare spending picked up slightly in 2015, reaching a total of $3.2 trillion, or $9,990 per person, in the country largely due to the expanded coverage of individuals who signed up for Obamacare, or those who took advantage of a major expansion of Medicaid. You can access of our complimentary research reports on these stocks now at:
Shares in Eagan, Minnesota-based Skyline Medical Inc. saw a decline of 2.89%, ending Monday's trading session at $3.02 with a total trading volume of 317,446 shares. The stock is trading 5.63% below its 50-day moving average. Shares of the Company, which manufactures environmentally conscientious system for the collection and disposal of infectious fluids that result from surgical procedures and post-operative care in the US, have a Relative Strength Index (RSI) of 49.45.
On December 02nd, 2016, Skyline Medical announced changes in executive management and its board of directors. Dr. Carl Schwartz, who currently serves as Executive Chairman, has been named the Company's CEO and will continue to serve as a director. Richard Gabriel, co-founder and Chief Operating Officer of GLG Pharma, has been appointed to the Company's board of directors, bringing the number of directors to six. Both appointments were announced to be effective immediately. Visit us today and download your complete report on SKLN for free at:
Deerfield, Illinois headquartered Baxter International Inc.'s stock declined 0.27%, closing the day at $43.89. A total volume of 7.13 million shares was traded, which was above their three months average volume of 4.49 million shares. The Company's shares have advanced 16.39% on an YTD basis. The stock is trading 2.04% below its 200-day moving average. Additionally, shares of Baxter International, which provides a portfolio of renal and hospital products, have an RSI of 35.59.
On December 05th, 2016, Baxter announced the launch of the Sigma Spectrum Safety Management System, which adds features designed to help minimize infusion programming risks. The first is Baxter's Infusion Analytics application, a software solution that provides advanced infusion data analysis and graphical reporting to help identify potential pump programming errors. The second is a suite of Remote Professional Services that offers 24/7 service and technical support along with regular cybersecurity monitoring and reporting. The complimentary research report on BAX can be accessed at:
On Monday, shares in York, Pennsylvania headquartered DENTSPLY Sirona Inc. recorded a trading volume of 2.16 million shares, which was higher than their three months average volume of 1.59 million shares. The stock ended the day 0.63% higher at $57.27. The Company's shares are trading below their 50-day moving average by 3.14%. Furthermore, shares of DENTSPLY Sirona, which designs, develops, manufactures, and markets various consumable dental products for the professional dental market in the US and internationally, have an RSI of 37.79.
On November 04th, 2016, DENTSPLY reported Q3 2016 net sales of $954.2 million, which increased 47.0% compared to $648.9 million in Q3 2015. Net income attributed to DENTSPLY Sirona for the reported quarter was $92.5 million, or $0.39 per diluted share, compared to $84.5 million, or $0.59 per diluted share, in Q3 2015.
Yesterday, research firm Barrington Research upgraded the Company's stock rating from 'Market Perform' to 'Outperform', issuing a target price of $63 per share. Register for free on Stock-Callers.com and download the PDF research report on XRAY at:
Boston, Massachusetts headquartered InspireMD Inc.'s stock rose 2.59%, finishing yesterday's session at $2.77 with a total trading volume of 43,185 shares. The Company's shares have surged 20.43% in the last one month, 1954.90% in the previous three months, and 214.77% on an YTD basis. The stock is trading above its 50-day and 200-day moving averages by 45.17% and 270.76%, respectively. Additionally, shares of InspireMD, which focuses on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of complex coronary and vascular diseases, have an RSI of 58.44.
On December 05th, 2016, InspireMD announced a change in its presentation time at the LD Micro 9th Annual Main Event on December 06th, 2016 in Los Angeles, California. CFO, Craig Shore, will now present at 4:30pm PT. Mr. Shore will provide a corporate overview and discuss the Company's proprietary MicroNet™ technology, which has been developed to address key issues found with current stenting options. Get free access to your research report on NSPR at:
Stock Callers (SC) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. SC has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.
SC has not been compensated; directly or indirectly; for producing or publishing this document.
PRESS RELEASE PROCEDURES:
The non-sponsored content contained herein has been prepared by a writer (the "Author") and is fact checked and reviewed by a third party research service company (the "Reviewer") represented by a credentialed financial analyst [for further information on analyst credentials, please email firstname.lastname@example.org. Rohit Tuli, a CFA® charterholder (the "Sponsor"), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by SC. SC is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.
SC, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. SC, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, SC, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.
NOT AN OFFERING
This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither SC nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit
For any questions, inquiries, or comments reach out to us directly. If you're a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:
Phone number: +44 330 808 3765
Office Address: Clyde Offices, Second Floor, 48 West George Street, Glasgow, U.K. -G2 1BP
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.
SOURCE Chelmsford Park SA